Wird geladen...
Development and validation of a tool to assess the risk of QT drug-drug interactions in clinical practice
BACKGROUND: The exact risk of developing QTc-prolongation when using a combination of QTc-prolonging drugs is still unknown, making it difficult to interpret these QT drug-drug interactions (QT-DDIs). A tool to identify high-risk patients is needed to support healthcare providers in handling automat...
Gespeichert in:
| Veröffentlicht in: | BMC Med Inform Decis Mak |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7376881/ https://ncbi.nlm.nih.gov/pubmed/32703198 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12911-020-01181-3 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|